Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway
This study indicates the potential application of HDAC3 inhibitor for the prevention of DCM.
Source: Clinical Science - Category: Biomedical Science Authors: Xu, Z., Tong, Q., Zhang, Z., Wang, S., Zheng, Y., Liu, Q., Qian, L., Chen, S.-y., Sun, J., Cai, L. Tags: PublishAheadOfPrint Source Type: research
More News: Biomedical Science | Cardiology | Cardiomyopathy | Diabetes | Diabetes Type 1 | Endocrinology | Genetics | Heart | Insulin | Science | Study